Stock search

Ticker or company name

Compare stocks

Market: US

  • LHLabcorp
  • DXCMDexcom
  • DGXQuest Diagnostics

Add stock

Ticker or company

Summary

LH
Labcorp
$372,46Up +0,53%
Year: Up +38%
56/100Ratio would watch
Open stock page
DXCM
Dexcom
$81,61Down −2,06%
Year: Up +40%
89/100Best scoreRatio would consider buying
Open stock page
DGX
Quest Diagnostics
$262,21Up +1,01%
Year: Up +38%
61/100Ratio would watch
Open stock page

Verdict

DXCM has the best score (89). DXCM grows revenue the fastest. LH is the cheapest by forward P/E. DXCM has the lowest debt load. DXCM has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckLH3 ✓ 4 — 2 ✕DXCM8 ✓ 0 — 1 ✕DGX3 ✓ 5 — 1 ✕
P/E vs its history30,031,425,5
P/E vs industry30,031,425,5
Forward P/E18,626,821,3
Revenue growth, YoY+6,0%+13,0%+9,1%
EPS growth, YoY+19,6%+41,1%+17,8%
Net margin6,9%19,4%9,5%
Net debt / EBITDA2,3−0,62,1
Free cash flow$1,29 bn$1,10 bn$1,38 bn
Share count over a year−2,5%−5,9%−0,9%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterLHTTMDXCMTTMDGXTTMIndustry medianTTM
P/E TTM ↓30,0Worst: 31,4Best: 25,525,1
Forward P/E ↓Best: 18,6Worst: 26,821,316,2
PEG ↓Worst: 3,2Best: 1,42,62,2
P/S TTM ↓Best: 2,1Worst: 6,12,42,2
EV/EBITDA ↓19,8Worst: 21,0Best: 17,917,3
P/FCF ↓23,4Worst: 28,3Best: 20,919,5

Price, %

  • LHn/a
  • DXCMn/a
  • DGXn/a

Returns

Best WorstNo mark — in between

PeriodLHDXCMDGX
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

LHDXCMDGX
Share of “buy”78%Best: 89%Worst: 52%
Beat the forecastWorst: 3 of 4Worst: 3 of 4Best: 4 of 4
Average “surprise”Worst: +0,6%+0,9%Best: +5,0%
Insiders over 12 monthssales $11,7 msales $12,2 msales $45,8 m

Details are on each stock page.